Role of β-catenin/T-cell factor-regulated genes in ovarian endometrioid adenocarcinomas

American Journal of Pathology

Volumn 160, Issue 4, 2002, Pages 1229-1238

  Zhai, Yali ^a   Wu, Rong ^a   Schwartz, Donald R ^a   Darrah, Danielle ^a   Reed, Heather ^a   Kolligs, Frank T ^a   Nieman, Marvin T ^a   Fearon, Eric R ^a   Cho, Kathleen R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXIN; BETA CATENIN; CONNEXIN 43; CYCLIN D1; GENE PRODUCT; MATRILYSIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEIN ITF2; T LYMPHOCYTE FACTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; WNT PROTEIN;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CELL NUCLEUS; CLINICAL ARTICLE; COLON POLYPOSIS; FEMALE; GENE EXPRESSION REGULATION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0036107888     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62550-3     Document Type: Article

References (60)

1. Wnt signaling: A common theme in animal development
2. Wnt signaling and cancer
3. Wnt signaling in oncogenesis and embryogenesis - A look outside the nucleus
4. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC
5. Beta-catenin mutations in cell lines established from human colorectal cancers
6. Stabilization of β-catenin by genetic defects in melanoma cell lines
7. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene
8. Sporadic medulloblastomas contain oncogenic β-catenin mutations
9. Beta-catenin mutations in human prostate cancer
10. Detection and analysis of beta-catenin mutations in prostate cancer
11. Beta-catenin mutation in carcinoma of the uterine endometrium
12. Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway
13. Mutational analysis of the CTNNB1 and APC genes in uterine endometrioid carcinoma
14. Frequent nuclear beta-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation
15. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer
16. Sequence variants of the axin gene in breast, colon, and other cancers: An analysis of mutations that interfere with GSK3 binding
17. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
18. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling
19. The APC tumour suppressor has a nuclear export function
20. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs
21. Identification of c-MYC as a target of the APC pathway
22. Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1
23. Identification of connexin43 as a functional target for Wnt signalling
24. Gastrin is a target of the beta-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis
25. The cyclin D1 gene is a target of the b-catenin/LEF-1 pathway
26. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells
27. The metalroproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors
28. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis
29. WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors
30. Wnt-1 regulation of connexin43 in cardiac myocytes
31. Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer
32. Id2 is a target of the beta-catenin/TCF pathway in colon carcinoma
33. Beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer
34. Correlation of betacatenin and cyclin D1 expression in colon cancers
35. Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas
36. Frequent deletions and mutations of the beta-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma
37. Beta-catenin expression pattern in stage I and II ovarian carcinomas: Relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome
38. Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas
39. Mutational analysis of beta-catenin gene in Japanese ovarian carcinomas: Frequent mutations in endometrioid carcinomas
40. Beta-catenin mutation and expression analysis in ovarian cancer: Exon 3 mutations and nuclear translocation in 16% of endometrioid tumours
41. Diverse mechanisms of betacatenin deregulation in ovarian endometrioid adenocarcinomas
42. Plasmacytoid differentiation of Epstein-Barr virus-transformed B cells in vivo is associated with reduced expression of viral latent genes
43. Beta-catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression
44. The concurrent expression of p27(kip1) and cyclin D1 in epithelial ovarian tumors
45. Overexpression of cyclin D1 in epithelial ovarian cancers
46. The p16-cyclin D1/CDK4-pRb pathway and clinical outcome in epithelial ovarian cancer
47. Altered expression of cyclin D1 and CDK4 genes in ovarian carcinomas
48. The matrix metalloprotease pump-1 (MMP-7, matrilysin): A candidate marker/target for ovarian cancer detection and treatment
49. Structure and expression of the human gene for the matrix metalloproteinase matrilysin
50. Gap junctional intercellular communication and connexin 43 expression in ovarian carcinoma
51. The role of E-proteins in B- and T-lymphocyte development
52. Differential interactions of Id proteins with basic-helix-loop-helix transcription factors
53. Preferred sequences for DNA recognition by the TAL1 helixloop-helix proteins
54. Involvement of adenomatous polyposis coli (APC)/beta-catenin signalling in human breast cancer
55. Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression
56. DNA ploidy and MYC DNA amplification in ovarian carcinomas. Correlation with p53 and bcl-2 expression, proliferative activity and prognosis
57. C-myc over-expression in human primary ovarian tumours: Its relevance to tumour progression
58. C-myc amplification in ovarian cancer
59. Inhibition of Wnt signaling by ICAT, a novel beta-catenin-interacting protein
60. Pin1 regulates turnover and subcellular localization of β-catenin by inhibiting its interaction with APC